Literature DB >> 2786032

Immune response to a molecularly defined internal image idiotope.

W V Williams1, S D London, D B Weiner, S Wadsworth, J A Berzofsky, F Robey, D H Rubin, M I Greene.   

Abstract

A monoclonal anti-idiotope termed 87.92.6 mimics the neutralization/cell-attachment site of the reovirus type 3 hemagglutinin (HA3). The second complementarity determining regions of the VH and VL of 87.92.6 share sequence similarity with a determinant on the HA3. We have used synthetic peptides (termed VH, VL, and Reo peptides, respectively) to probe the immunologic significance of this sequence similarity. Antibodies specific for Reo peptide or VL peptide neutralized reovirus type 3 infectivity. Although Reo peptide was an effective immunogen by itself, free VL peptide or VH peptide were unable to elicit antibodies unless they were linked to each other (VH-VL peptide). Immunization with reo peptide, 87.92.6, or the HA3 elicited a specific lymphocyte proliferative response to VH peptide, indicating that VH peptide may bear an important TH determinant. As found previously for 87.92.6, VL peptide elicited a delayed-type hypersensitivity response specific for reovirus type 3. Reovirus type 3 specific cytolytic lymphocytes specifically lysed targets coated with VH-VL peptide, but not VH or VL peptide alone. These results suggest that immune cross-reactivity between an external Ag and an internal image antibody can be understood at the primary structural level. These observations may have important implications for understanding the development of autoantibodies, network interactions, and the regulation of immune responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786032

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Modulation of T cell responses with MHC-derived peptides.

Authors:  W V Williams; D B Weiner; M A Borofsky; D H Rubin; K Yui; M I Greene
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 2.  An idiotope--anti-idiotope complex and the structural basis of molecular mimicking.

Authors:  R J Poljak
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

Review 3.  The antigen-major histocompatibility complex-T cell receptor interaction. A structural analysis.

Authors:  W V Williams; D B Weiner; S Wadsworth; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

4.  Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice.

Authors:  C F Cuff; E Lavi; C K Cebra; J J Cebra; D H Rubin
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.

Authors:  T A Oosterlaken; M Harmsen; S S Jhagjhoor-Singh; G L Ekstijn; C A Kraaijeveld; H Snippe
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  Role of immune cells in protection against and control of reovirus infection in neonatal mice.

Authors:  H W Virgin; K L Tyler
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.

Authors:  K A Foon; M Chakraborty; W J John; A Sherratt; H Köhler; M Bhattacharya-Chatterjee
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Peptide mimicry of the meningococcal group C capsular polysaccharide.

Authors:  M A Westerink; P C Giardina; M A Apicella; T Kieber-Emmons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide.

Authors:  M W Pride; H Shi; J M Anchin; D S Linthicum; P T LoVerde; A Thakur; Y Thanavala
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Structure based antibody-like peptidomimetics.

Authors:  Ramachandran Murali; Mark I Greene
Journal:  Pharmaceuticals (Basel)       Date:  2012-02-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.